Publication | Open Access
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
38
Citations
33
References
2020
Year
These data indicate that LAG3 is a key bottleneck to successful PI3Kδ-targeted immunotherapy and provide a rationale for combining PI3Kδ/LAG3 blockade in future clinical studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1